Prostacyclin pathway vasodilators in patients with chronic thromboembolic pulmonary hypertension (CTEPH): A systemic review and meta‐analysis of randomized controlled trials

Abstract Although surgical and interventional therapy has emerged as the primary treatment for patients with chronic thromboembolic pulmonary hypertension (CTEPH), there remains a subset of patients who need medication therapy. This study aimed to evaluate the efficacy and safety outcomes of prostac...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Weijun Li, Xingxue Pang, Jun Chen, Xiaoxia Ren, Huaibing Zhao, Xu Wang, Ning Zhao, Dayi Hu, Zhongyi Jin
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2024-10-01
Edice:	Pulmonary Circulation
Témata:	chronic thromboembolic pulmonary hypertension prostacyclin pulmonary hypertension
On-line přístup:	https://doi.org/10.1002/pul2.70001
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!